Search

Your search keyword '"MESH : Gene Expression Regulation, Neoplastic"' showing total 32 results

Search Constraints

Start Over You searched for: Descriptor "MESH : Gene Expression Regulation, Neoplastic" Remove constraint Descriptor: "MESH : Gene Expression Regulation, Neoplastic"
32 results on '"MESH : Gene Expression Regulation, Neoplastic"'

Search Results

1. Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice

2. Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia

3. EWS-FLI1 inhibits TNFα-induced NFκB-dependent transcription in Ewing sarcoma cells

4. miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers

5. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis

6. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism

7. The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft model

8. Mechanisms Regulating Tumor Angiogenesis by 12-Lipoxygenase in Prostate Cancer Cells

9. Targeting c-FLIP in cancer

10. Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis

11. [Ki67, nucleolus and cancer]

12. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells

13. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells

14. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

15. Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells

16. 1q12 chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma

17. In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy

18. The SNAIL family member SCRATCH1 is not expressed in human tumors

19. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

20. Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer

21. A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells

22. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

23. Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

24. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome

25. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. : hepatocellular tumors miRNA profiling

26. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation

27. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.: Transcriptome and HCC classification

28. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors

29. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short)

30. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy

31. Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques

32. JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress

Catalog

Books, media, physical & digital resources